United States, North Carolina — Durham, North Carolina

United States, North Carolina is a clinical research site located in Durham, North Carolina, United States 27710.

Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.

United States, North Carolina has participated in 5 clinical trials.

Therapeutic areas: Includes: Hereditary Angioedema, Epilepsy, Glioma.

Sponsors: CSL Behring, UCB Biopharma S.P.R.L., Institut de Recherches Internationales Servier.

Sponsor Feasibility Report

Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for United States, North Carolina?

United States, North Carolina has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has United States, North Carolina conducted?

United States, North Carolina has 5 clinical trials on record. Their work covers Includes: Hereditary Angioedema, Epilepsy, Glioma.

Is United States, North Carolina accredited by Crixeo Health?

United States, North Carolina has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about United States, North Carolina?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.